Update on laser subepithelial keratectomy (LASEK)

Current Opinion in Ophthalmology

Volumn 15, Issue 4, 2004, Pages 333-341

  Yee, Richard W ^a   Yee, Steven B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

LASEK; LASIK; Outcomes; Refractive surgery

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; ANTIBIOTIC AGENT; ASCORBIC ACID; BRIMONIDINE; DEXTROPROPOXYPHENE NAPSILATE; DICLOFENAC; FLUOROMETHOLONE; HYDROCODONE BITARTRATE; KETOROLAC TROMETAMOL; MITOMYCIN C; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PARACETAMOL; PETHIDINE; PROXYMETACAINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TETRACAINE; TOBRAMYCIN;

AGE DISTRIBUTION; ANALGESIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CORNEA SURGERY; HUMAN; HYPERMETROPIA; INFECTION PREVENTION; LASER EPITHELIAL KERATOMILEUSIS; OUTCOMES RESEARCH; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PUPIL; REVIEW; SAFETY; STEROID THERAPY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TOPICAL ANESTHESIA; TOPICAL TREATMENT; TREATMENT OUTCOME; VISUAL ACUITY;

HUMANS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; KERATOMILEUSIS, LASER IN SITU; POSTOPERATIVE COMPLICATIONS; REFRACTIVE ERRORS; VISUAL ACUITY;

EID: 3242721189     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200408000-00010     Document Type: Review

References (57)

1. Market Scope 2002. Available at: http://www.tlcv.com/newsroom/media_ kit/TLC%20LVC%20By%20the%20Numbers.pdf. Accessed February 2, 2004.
2. Seiler T, Wollensak J: Myopic photorefractive keratectomy with the excimer laser; one-year follow-up. Ophthalmology 1991, 98:1156-1163.
3. Salz JJ, Maguen E, Macy JI, et al.: One-year results of excimer laser photorefractive keratectomy for myopia. Refract Cornea Surg 1992, 8:269-273.
4. Salz JJ, Maguen E, Nesburn AB, et al.: A two-year experience with excimer laser photorefractive keratectomy for myopia. Ophthalmology 1993, 100:873-882.
5. Gartry DS, Kerr Muir MG, Marshall J: Photorefractive keratectomy with an argon fluoride excimer laser: a clinical study. Refract Corneal Surg 1991, 7:420-435.
6. Gartry DS, Kerr Muir MG, Marshall J: Excimer laser photorefractive keratectomy; 18 month follow-up. Ophthalmology 1992, 99:1209-1219.
7. Hersh PS, Brint SF, Maloney RK, et al.: Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia; a randomized prospective study. Ophthalmology 1998, 105:1512-1522; discussion by JH Talamo, 1522-1523.
8. Pop M, Aras M: Multizone/multipass photorefractive keratectomy: six month results. J Refract Surg 1995, 21:633-643.
9. Zhao K, Wang Y, Zuo T, Wang H: Multizone and transition zone photorefractive keratectomy for high myopia. J Refract Surg 1998, 14:S222-S225.
10. Kitazawa Y, Mackawa E, Sasaki S, et al.: Cooling effect on excimer laser photorefractive keratectomy. J Cataract Refract Surg 1999, 25:1349-1355.
11. Wang Z, Chen J, Yang B: Comparison of laser in situ keratomileusis and photorefractive keratectomy to correct myopia from -1.25 to -6.00 diopters. J Refract Surg 1997, 13:528-534.
12. Lowenstein A, Lipshitz I, Varssano D, Lazar M: Complications of excimer laser photorefractive keratectomy for myopia. J Cataract Refract Surg 1997, 23:1174-1176.
13. Alio JL, Artola A, Claramonte PJ, et al.: Complications of photorefractive keratectomy for myopia: two year follow-up of 3000 cases. J Cataract Refract Surg 1998, 24:619-626.
14. Ambrosio R, Wilson SE: LASIK vs LASEK vs PRK: Advantages and indications. Semin Ophthalmol 2003, 18:2-10. This detailed article discusses the advantages and disadvantages of the three refractive surgeries.
15. Number of LASIK procedures performed in the United States: Available at: http://www.bausch.com/us/resource/surgical/refractive/evolution.jsp. Accessed February 2, 2004.
16. Chalita MR, Tekwani NH, Krueger RR: Laser epithelial keratomileusis: outcome of initial cases performed by an experienced surgeon. J Refract Surg 2003, 19:412-415. This paper discusses the LASEK results in the hands of an experienced practitioner.
17. Wilson SE: LASIK: management of common complications. Cornea 1998, 17:459-467.
18. Melki SA, Talamo JH, Demetriades A-M, et al.: Late traumatic dislocation of laser in situ keratomileusis corneal flaps. Ophthalmology 2000, 107:2136-2139.
19. Yu EYW, Leung A, Rao S, Lam DSC: Effect of laser in situ keratomileusis on tear stability. Ophthalmology 2000, 107:2131-2135.
20. Smith RJ, Maloney RK: Diffuse lamellar keratitis; a new syndrome in lamellar refractive surgery. Ophthalmology 1998, 105:1721-1726.
21. Walker MB, Wilson SE: Incidence and prevention of epithelial growth within the interface after laser in situ keratomileusis. Cornea 2000, 19:170-173.
22. Durairaj VD, Balentine J, Kouyoumdjian G, et al.: The predictability of corneal flap thickness and tissue laser ablation in laser in situ keratomileusis. Ophthalmology 2000, 107:2140-2143.
23. Wang Z, Chen J, Yang B: Posterior corneal surface topographic changes after laser in situ keratomileusis are related to residual corneal bed thickness. Ophthalmology 1999, 106:406-409; discussion 409-410.
24. Epstein D, Fagerholm P, Hamberg-Nystrom H, Tengroth B: Twenty-four month follow-up of excimer laser photorefractive keratectomy for myopia; refractive and visual acuity results. Ophthalmol 1994, 101:1558-1563; discussion 1563-1564.
25. Koch DD, Kohnen T, Obstbaum SA, Rosen ES: Format for reporting refractive surgical data. J Cataract Refract Surg 1998, 24:285-287.
26. Miller JM, Anwaruddin R, Straub J, Schwiegerling J: Higher order aberrations in normal, dilated, Intra-ocular lens, and laser in situ keratomileusis corneas. J Refract Surg 2002, 18:579-583.
27. Pallikaris IG, et al.: Induced optical aberrations following formation of a laser in situ keratomileusis flap. J Cataract Refract Surg 2002, 28:1737-1741.
28. Wilson SE, Mohan RR, Hong JW, et al.: The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Arch Ophthalmol 2001, 119:889-896.
29. Camellin M: Laser Epithelial Keratomileusis for Myopia. J Refract Surg 2003, 19:666-670. This article describes specific LASEK techniques and the rationale behind them.
30. Vinciguerra P, Camesasca F, Randazzo A: One-year results of butterfly laser epithelial keratomileusis. J Refract Surg 2003, 19:S223-S226. This article discusses the techniques and outcome of yet another method of performing LASEK.
31. McDonald MB: Binkhorst Lecture: Refractive Surgery: The Next Generation. American Academy of Ophthalmology 2001 Annual Meeting. American Academy of Ophthalmology: New Orleans.
32. Arshinoff SA, Opalinski Y: The pharmacotherapy of photorefractive keratectomy. Comp Ophthalmol Update 2003, 4:225-233. This paper details the role of specific pharmacologic agents in laser surface ablation.
33. Jackson WB: When complications come to the surface [Review of Ophthalmology website]. July 15, 2003. Available at: http://www.revophth. com/index.asp?page=1_363.htm. Accessed: January 5, 2004.
34. Guttman C, McDonald J: Undercorrected hyperopia can be treated with NSAID, contact lens. [Ophthalmology Times website]. March 1, 2003. Available at: http://www.ophthalmologytimes.com/ophthalmologytimes/article/articleDetail. jsp?id=47062. Accessed: January 5, 2004
35. Tsubota K, Goto E, Shimmura S, Shimazki J: Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999, 106:1984-1989.
36. Tsubota K, Goto E, Fujita H, et al.: Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999, 83:390-395.
37. Pastor JC, Calonge M: Epidermal growth factor and corneal wound healing: a multicenter study. Cornea 1992, 11:311-314.
38. Yee SB, Lin N, Chuang AZ, Yee RW: The efficacy of autologous serum in post-laser epithelial keratectomy (LASEK) patients (poster). Association for Research in Vision and Ophthalmology 2003; Fort Lauderdale FL. This poster discusses the preparation, use, and outcome of autologous serum eye drops in LASEK.
39. Williams RN, Paterson CA: Modulation of corneal lipoxygenase by ascorbic acid. Exp Eye Res 1986, 43:7-13.
40. Shimmura S, Masumizu T, Nakai Y: Excimer laser-induced hydroxyl radical formation and keratocytes death in vitro. Invest Ophthalmol Vis Sci 1999, 40:1245-1249.
41. Corbett MC, Prydal JI, Verma S: An in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function. Ophthalmol 1996, 103:1366-1380.
42. Kaufman PL: Aqueous humor dynamics. In Duane's Clinical Ophthalmology, vol 3. Edited by Tasman W. New York, NY: Lippincott-Raven; 1997:3-4.
43. Gonul B, Kaplan B, Bilgihan K, Budak MT: Effects of epidermal growth factor in artificial tear on vitamin C levels of corneal wounded eye tissues. Eye 2001, 15:213-216.
44. Bilgihan A, Bilgihan K, Toklu Y: Ascorbic acid levels in human tears after photorefractive keratectomy, transepithelial photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2001, 27:585-588.
45. Bilgihan A, Bilgihan K, Akata F, et al.: Excimer laser corneal surgery and free oxygen radicals. Jpn J Ophthalmol 1996, 40:154-157.
46. Stojanovic A, Ringvold A, Nitter T: Ascorbate prophylaxis for corneal haze after photorefractive keratectomy. J Refract Surg 2003, 19:338-343. This paper discusses the role of oral ascorbate in the prophylaxis of corneal haze in PRK.
47. Kasetsuwan N, Wu FM, Hsieh F, et al.: Effects of topical ascorbic acid on free radical tissue damage and inflammatory cell influx in the cornea after excimer laser corneal surgery. Arch Ophthalmol 1999, 117:649-652.
48. Majmudar PA, Forstot SL, Dennis RF: Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmol 2000, 107:89-94.
49. Vigo L, Scandola E, Carones F: Scraping and mitomycin-C to treat haze and regression after photorefractive keratectomy for myopia. J Refract Surg 2003, 19:449-454.
50. Porges Y, Ben-Haim O, Hirsh A, Levinger S: Phototherapeutic keratectomy with mitomycin-C for corneal haze following photorefractive keratectomy for myopia. J Refract Surg 2003, 19:40-43. This article describes the treatment of corneal haze post-PRK using a combination of laser and pharmacologic therapies.
51. nd, El-Moatassem Kolb AM, Decker BB: Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions. J Cataract Refract Surg 2001, 27:560-564.
52. Feit R, Taneri S, Azar DT, et al.: LASEK results. Ophthalmol Clin N Am 2003, 16:127-135. This paper discusses in detail both the safety and efficacy of LASEK.
53. Autrata R, Rehurek J: Laser-assisted subepithelial keratectomy for myopia: two-year follow-up. J Cataract Refract Surg 2003, 29:661-668. A longer follow-up time in this series of LASEK patients is a noteworthy feature of this paper.
54. Yo C, Vroman C, Ma S, et al.: Surgical outcomes of photorefractive keratectomy and laser in situ keratomileusis by inexperienced surgeons. J Cataract Refract Surg 2000, 26:510-515.
55. Knorz MC, Jendritza B, Liermann A, et al.: LASIK for myopia correction. 2-year follow-up. Ophthalmologe 1998, 95:494-498.
56. Oshika T, Miyata K, Tokunaga T, et al.: Higher order wavefront aberrations of cornea and magnitude of refractive correction in laser in situ keratomileusis. Ophthalmology 2002, 109:1154-1158.
57. Moreno-Barriuso E, Lloves JM, Marcos S, et al.: Ocular aberrations before and after myopic corneal refractive surgery: LASIK-induced changes measured with laser ray tracing. Invest Ophthalmol Vis Sci 2001, 42:1396-1403.